On November 3, 2021 Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease with three ongoing Phase 1 clinical trials, reported that company management will participate in four virtual investor conferences in November 2021 (Press release, Shattuck Labs, NOV 3, 2021, View Source [SID1234594247]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details

Conference: Berenberg US CEO Conference 2021
Format: 1×1 meetings
Date: November 10, 2021

Conference: Cowen 4th Annual IO Next Summit
Format: Fireside chat with covering analyst, Marc Frahm, Ph.D.
Presenter: Taylor Schreiber, M.D., Ph.D., Shattuck’s Chief Executive Officer
Date: November 15, 2021
Time: 1:45 p.m. EST

Conference: Piper Sandler 33rd Annual Healthcare Conference
Format: Corporate presentation
Presenter: Taylor Schreiber, M.D., Ph.D., Shattuck’s Chief Executive Officer
Date: November 22, 2021
Time: 10:00 a.m. EST

Conference: Evercore ISI 4th Annual HealthCONx Conference
Format: Fireside chat with covering analyst, Umer Raffat
Presenter: Taylor Schreiber, M.D., Ph.D., Shattuck’s Chief Executive Officer
Date: December 3, 2021
Time: 1:50 p.m. EST

A live webcast of the fireside chats and presentations will be available on the Events & Presentations section of the Company’s website. A replay of the webcasts will be archived for up to 90 days following the presentation date.